top of page
PLASBIO
Background
비임상 시장 규모
제약 및 의학 기술수요가 증가하며 비임상 시장이 전세계적으로 성장중
비임상 시장 현황
Post-COVID 19 시대를 맞아 제약 및 의학 기술수요 증가로 인한
전세계적 비임상 시장 성장과 AI 신약개발 시장의성장
파급효과
지적재산권
PLASBIO
기술융합을 통해 새로운 가치를
창조하는 기업
국내 특허
출원/등록
21
해외 특허
(미국)
2
PCT
5
상표권
6
앵커 6
플라스바이오는 점차 성장하는 바이오 시장에 발맞추어
동물실험 자동화 솔루션을 구축하는 기술중심 기업입니다.
우리는 인종지능과 3D 프린팅, 로보틱스 등 경쟁력있는
기술로 새로운 가치를 창출하는 기업이 되고 있습니다.
2018
2019
Conversion start-up:
R&D, manufacturing
Established Ezmakers
(3D printing education service business)
2020
Founded in 2020 (PLASBIO Inc.)
Microsoft-Korea Ministry of SMEs
and Startups (Majoong program)
Moved into Jeonju CAMTIC Advanced
Mechatronics Technology Institute
Chicago Matter Global member
in the United States
A mHUB Global Member in the United States
A member of TIPA
Korea Atomic Energy Research Institute KAERI
Family corporate certification
Founded the research center
Moved into the Korea Atomic Energy Research
Institute RFT commercialization
Research building
Certified as a company with excellent technologies
(Labware customized for lab animal studies)
2021
2022
2023
The 1st generation of IBK
Changgong Daejeon
KRIBB family company
TIPS R&D
INFORBENK, The Next Lab
KB Investment
Certification of venture enterprise
Dod-umgieob of Jeollabuk-do Province
Co-research: JOHNS HOPKINS
INSTITUTE for NANOBIOTECHNOLOGY
Selected as a supplier of KAIST's
biosynthesis research team
Ocean Bio signed an EVIO MOU
Btree MOU, NDA signed
First round of investment
Second round of investment
Expansion of Daejeon branch
Society of Neuroscience 2022 Announcement
73rd AALAS Excellent Research Poster Award
KBSI Convergence Innovation Team
BIO KOREA 2022 Smart Inject launch
First Penguin by Credit Guarantee Fund
BIO KOREA 2023 Smart Inject launch
AI voucher supplier selection
NVDIA inception program selection
CES 2024 innovation award
bottom of page